Particle.news
Download on the App Store

Corona Remedies IPO Sees Up To 144.54x Bids as Allotment Decision Arrives

Institutional demand led the offer-for-sale ahead of a December 15 listing.

Overview

  • Updated tallies reported total subscription at 144.54x after the window closed, while NSE’s final-day figure showed 137.04x.
  • By category, NSE data showed QIB bids at 278.52x, NIIs at 208.88x, and retail at 28.73x.
  • Share allotment is slated to be finalised on December 11, with investors able to check status on BSE, NSE and the registrar’s portal.
  • Grey-market signals strengthened, with a reported premium of Rs 295 and unlisted quotes near Rs 1,357, suggesting expectations of a premium listing.
  • The issue is a pure OFS by promoters and investors including Sepia Investments, Anchor Partners and Sage Investment Trust, priced at Rs 1,008–1,062 after raising Rs 195 crore from anchors.